These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8990939)

  • 1. [Usefulness of the modified Greipp's morphological classification of multiple myeloma cells].
    Ohata M; Nakamura S; Kuroyama Y
    Rinsho Byori; 1996 Dec; 44(12):1189-95. PubMed ID: 8990939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of morphological classification in multiple myeloma.
    Murakami H; Nemoto K; Sawamura M; Tamura J; Matsushima T; Naruse T; Tsuchiya J; Sato S; Shiamano S; Shinonome S
    Acta Haematol; 1992; 87(3):113-7. PubMed ID: 1642091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic significance of cytological study of the bone marrow in multiple myeloma].
    Iakovleva SV
    Ter Arkh; 2000; 72(7):48-51. PubMed ID: 10983321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow morphology in multiple myeloma.
    Kuriakose P; Das S; Mani A
    Indian J Cancer; 1995 Sep; 32(3):100-3. PubMed ID: 8772808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].
    Moro MJ; Portero JA; Gascón A; Hernández JM; Ortega F; Jiménez R; Guerras L; Martínez M; Casanova F; Sanz MA
    Sangre (Barc); 1992 Jun; 37(3):175-9. PubMed ID: 1440094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of plasma cell morphology in multiple myeloma.
    Paule B; Quillard J; Bisson M; Kahn MF; Massias P
    Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
    Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
    Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
    Paule B; Quillard J; Bennet P; Mariette X; Bisson M
    Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.
    Filipits M; Pohl G; Stranzl T; Kaufmann H; Ackermann J; Gisslinger H; Greinix H; Chott A; Drach J
    Clin Cancer Res; 2003 Feb; 9(2):820-6. PubMed ID: 12576455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological and histological classification of multiple myeloma.
    Wutke K; Várbíró M; Rüdiger KD; Kelényi G
    Haematologia (Budap); 1981; 14(3):315-29. PubMed ID: 7327443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.
    Rifkin RM; Gregory SA; Mohrbacher A; Hussein MA
    Cancer; 2006 Feb; 106(4):848-58. PubMed ID: 16404741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histomorphology of multiple myeloma on bone marrow biopsy.
    Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
    Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
    Paule B; Quillard J; Bennet P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.
    Hussein MA; Wood L; Hsi E; Srkalovic G; Karam M; Elson P; Bukowski RM
    Cancer; 2002 Nov; 95(10):2160-8. PubMed ID: 12412170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine, doxorubicin, and dexamethasone or thalidomide plus dexamethasone for newly diagnosed patients with multiple myeloma?
    Jimenez-Zepeda VH; Domínguez-Martínez VJ
    Eur J Haematol; 2006 Sep; 77(3):239-44. PubMed ID: 16856924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure of myeloma cells in patients with common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma.
    Kurabayashi H; Kubota K; Murakami H; Tamura J; Sawamura M; Nogiwa E; Shinonome S; Miyawaki S; Sato S; Omine M
    Cancer Res; 1988 Nov; 48(21):6234-7. PubMed ID: 2971435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.